Dabigatran Etexilate: Clinical Implications in Dermatologic SurgeryBOTA, James P; LEBLANC, Keith G; SHEEHAN, Daniel J et al.Dermatologic surgery. 2012, Vol 38, Num 4, pp 675-676, issn 1076-0512, 2 p.Article

Development and Validation of a Stability-Indicating Liquid Chromatography Method for the Determination of Dabigatran Etexilate in CapsulesBERNARDI, Raquel M; FRÖEHLICH, Pedro E; BERGOLD, Ana M et al.Journal of AOAC International. 2013, Vol 96, Num 1, pp 37-41, issn 1060-3271, 5 p.Article

Dabigatran etexilate: a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityVAN RYN, Joanne; STANGIER, Joachim; HAERTTER, Sebastian et al.Thrombosis and haemostasis. 2010, Vol 103, Num 6, pp 1116-1127, issn 0340-6245, 12 p.Article

Using the HEMOCLOT direct thrombin inhibitor assay to determine plasma concentrations of dabigatranSTANGIER, Joachim; FEURING, Martin.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 2, pp 138-143, issn 0957-5235, 6 p.Article

Dabigatran (Pradaxa^®): efficacité et tolérance = Dabigatran (Pradaxa^®): efficacy and safetyROSENCHER, N; BELLAMY, L.Annales françaises d'anesthésie et de réanimation. 2009, Vol 28, Num SEPT, issn 0750-7658, S15-S22, SUP1Article

Dabigatran etexilateDUBOIS, Eline A; COHEN, Adam F.British journal of clinical pharmacology. 2010, Vol 70, Num 1, pp 14-15, issn 0306-5251, 2 p.Article

Dabigatran EtexilateSANFORD, Mark; PLOSKER, Greg L.Drugs (Basel). 2008, Vol 68, Num 12, pp 1699-1709, issn 0012-6667, 11 p.Article

Cytolyse hépatique sous dabigatran étexilate chez un sujet âgé = Cytolysis in an Elderly Patient Treated with Dabigatran EtexilateFULCRAND, Julie; LEROOY, Alexandre; GIRAUD, Jean et al.Thérapie (Paris). 2013, Vol 68, Num 5, pp 332-334, issn 0040-5957, 3 p.Article

Novel oral anticoagulants - key messages for the angiologistHAAS, Sylvia; SPANNAGL, Michael; SCHELLONG, Sebastian M et al.VASA (Bern). 2012, Vol 41, Num 3, pp 177-191, issn 0301-1526, 15 p.Article

LES NOUVEAUX ANTITHROMBOTIQUES ORAUX = NEW ORAL ANTICOAGULANTSSCHMIDT, J; BREUIL, N; HEUSER, S et al.Médecine d'urgence (Paris). 2009, Vol 31, Num SEPT, pp 346-350, issn 1148-8115, 5 p., NSConference Paper

Les inhibiteurs directs de la thrombine, l'hirudine, la bivalirudine, l'argatroban, et le dabigatran etexilate = Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilateMEDDAHI, S; SAMAMA, M. M.Journal des maladies vasculaires. 2011, Vol 36, Num 1, pp 24-32, issn 0398-0499, 9 p.Article

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients : a population model analysisLIESENFELD, Karl-Heinz; SCHÄFER, Hans G; TROCONIZ, Inaki F et al.British journal of clinical pharmacology. 2006, Vol 62, Num 5, pp 527-537, issn 0306-5251, 11 p.Article

Le Dabigatran Etexilate (Pradaxa®) en pratique Guide d'utilisation dans les situations particulièresHERMANS, C; HEIDBÜCHEL, H; THIJS, V et al.Louvain médical. 2012, Vol 131, Num 1, pp 5-10, issn 0024-6956, 6 p.Article

Pradaxa^® (_Dabigatran _Etexilate) et chirurgie orthopédique: pourquoi, pour qui et comment ?HERMANS, C.Louvain médical. 2010, Vol 129, Num 5, pp 161-167, issn 0024-6956, 7 p.Article

Oral anticoagulants in development : Focus on thromboprophylaxis in atients undergoing orthopaedic surgeryERIKSSON, Bengt I; QUINLAN, Daniel J.Drugs (Basel). 2006, Vol 66, Num 11, pp 1411-1429, issn 0012-6667, 19 p.Article

Plasma-Diluted Thrombin Time to Measure Dabigatran Concentrations During Dabigatran Etexilate TherapyAVECILLA, Scott T; FERRELL, Chris; CHANDLER, Wayne L et al.American journal of clinical pathology. 2012, Vol 137, Num 4, pp 572-574, issn 0002-9173, 3 p.Article

A combined pharmacometric analysis of dabigatran etexilate in healthy volunteers and patients with atrial fibrillation or undergoing orthopaedic surgeryDANSIRIKUL, Chantaratsamon; LEHR, Thorsten; LIESENFELD, Karl-Heinz et al.Thrombosis and haemostasis. 2012, Vol 107, Num 4, pp 775-785, issn 0340-6245, 11 p.Article

Acute Stroke Management in Patients Taking DabigatranBROUNS, Raf; VAN HOOFF, Robbert-Jan; DE SMEDT, Ann et al.CNS neuroscience & therapeutics (Print). 2012, Vol 18, Num 8, pp 616-622, issn 1755-5930, 7 p.Article

In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilateWIENEN, Wolfgang; STASSEN, Jean-Marie; PRIEPKE, Henning et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 155-162, issn 0340-6245, 8 p.Article

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. CommentaryQING MA; STANGIER, Joachim; RATHGEN, Karin et al.British journal of clinical pharmacology. 2007, Vol 64, Num 3, issn 0306-5251, 263-265, 292-303 [15 p.]Article

Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patientsAGENO, Walter; SPYROPOULOS, Alex C; TURPIE, Alexander G. G et al.Thrombosis and haemostasis. 2012, Vol 107, Num 6, pp 1027-1034, issn 0340-6245, 8 p.Article

Use of anticoagulants in elderly patientsBAUERSACHS, Rupert M.Thrombosis research. 2012, Vol 129, Num 2, pp 107-115, issn 0049-3848, 9 p.Article

Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in ratsWIENEN, Wolfgang; STASSEN, Jean-Marie; PRIEPKE, Henning et al.Thrombosis and haemostasis. 2007, Vol 98, Num 2, pp 333-338, issn 0340-6245, 6 p.Article

Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: No increased risk of bleedingFRIEDMAN, Richard J; KURTH, Andreas A; CLEMENS, Andreas et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 183-190, issn 0340-6245, 8 p.Article

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profileCLEMENS, Andreas; RYN, Joanne Van; SENNEWALD, Regina et al.European journal of clinical pharmacology. 2012, Vol 68, Num 5, pp 607-616, issn 0031-6970, 10 p.Article